ARRB1 and hepatocellular carcinoma: Recent data has suggested that ARRB1 promotes hepatocellular carcinoma cell invasion and metastasis through p-ERK1/2-mediated EMT, and thus the suppression of p-ERK1/2 may offer potential therapeutic targets for hepatocellular carcinoma therapy 39.